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Abstract: Kisspeptin signaling is a potent regulator of the reproductive axis and an elicitor of gonadotropin-releasing hormone secretion.
The present study assessed the effect of the peripheral administration of a kisspeptin antagonist (P234) on testosterone secretion in the
adult male rhesus monkey. Five monkeys were administered with either P234 (38.8 µg/kg body weight) or a vehicle (0.9% saline).
Plasma testosterone and adiponectin levels, as a positive control, were then measured using specific ELISA assays from blood samples
collected sequentially at 15-min intervals from 60 min prior to until 360 min after the P234/vehicle injection. In 3 monkeys, the
experiment was repeated where the animals received a kisspeptin-10 (50 µg) challenge 30 min after the P234 or vehicle treatment.
No effects on basal testosterone levels were found after the systemic administration of P234. Plasma adiponectin levels were found
to be briefly decreased by P234. P234 administration was found to suppress kisspeptin-dependent testosterone release and to inhibit
kisspeptin-dependent adiponectin release. This suggested that the systemic administration of P234 was effective peripherally. However,
the minimal peripheral effects on testosterone secretion in the male macaque suggested that P234 did not cross the blood–brain barrier
and blocked the peripheral kisspeptin receptors.
Key words: Kisspeptin, peptide 234, testosterone, rhesus monkey, adiponectin, reproduction

1. Introduction
Kisspeptin neurons have been identified as the key
neuroendocrine system in the regulation of the
hypothalamic–pituitary–gonadal (HPG) axis, acting
one step upstream of gonadotropin-releasing hormone
(GnRH) neurons (Smith et al., 2005a, 2005b; Oakley et al.,
2009). GnRH neurons express GPR54, a G-protein coupled
receptor targeted by kisspeptin (Lee et al., 1999; Muir et
al., 2001; Brailoiu et al., 2005). A sufficient kisspeptinergic
drive to GnRH neurons has been found to be necessary
to maintain fertility in human males (Dhillo et al., 2005)
and a disruption of this system has been associated with
a wide variety of reproductive development problems.
For example, inactivating mutations in GPR54 lead to a
normosmic form of hypogonadotropic hypogonadism
in humans (de Roux et al, 2003; Seminara et al., 2003)
and an activating mutation of GPR54 was found to cause
precocious puberty (Teles et al., 2008). In addition, GPR54
knock-out mice fail to make pulsatile luteinizing hormone
(LH) and follicle-stimulating hormone secretions and do
not undergo puberty (Funes et al., 2003).
* Correspondence: tanzeelhuma@gmail.com
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KiSS-1 (encoding kisspeptins) and GPR54 gene
expression has been noted in the hypothalamus of
nonprimates (Smith et al., 2005a, 2005b), nonhuman
primates (Shahab et al., 2005), and humans (Muir et al.,
2001) and has been found to be regulated by a number
of mechanisms. For example, season and metabolic
status have been shown to regulate the expression of
KiSS-1 (Simonneaux et al., 2009; Wahab et al., 2011). Sex
hormones have also been found to regulate the expression
of KiSS-1 mRNA in the periventricular nucleus and
anteroventral periventricular nucleus of both male and
female mice (Smith et al., 2005a, 2005b). Interestingly,
gonadectomy was found to increase KiSS-1 mRNA levels in
the arcuate nucleus of rats, and this increased transcription
was lowered with sex steroid replacement (Navarro et al.,
2004). This evidence suggested the existence of a feedback
mechanism involved in the regulation of kisspeptin
transcription, expression, and secretion, which might
ultimately regulate reproductive function.
The pivotal role of kisspeptin-GPR54 signaling in
reproductive function has been demonstrated in a number
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of pharmacological (Shahab et al., 2005; Wahab et al., 2010)
and gene expression (Brown et al., 2008) studies. However, the
physiological significance of this signaling has not been well
characterized. This may be due to the lack of physiological
evidence, which had been difficult to ascertain because of
the absence of a potent kisspeptin antagonist. In recent years,
the discovery of a kisspeptin antagonist, peptide 234 (P234),
and its use in animal investigations has helped to shed light
on the role of endogenous kisspeptin signaling in regulating
the reproductive axis. These studies have provided detailed
evidence for a physiological role of kisspeptin signaling in
regulating GnRH secretion in mammals (Shahab et al., 2005;
Brown et al., 2008; Roseweir et al., 2009; Wahab et al., 2010;
Pineda et al., 2010; Guerriero et al., 2012). However, few
studies have been directed at examining testosterone release
in primates in response to peripheral kisspeptin, and the few
studies that have used P234 have predominantly administered
the antagonist centrally within the nervous system. Although
these studies have provided fruitful information into the role
of kisspeptin signaling, they have been limited in investigating
kisspeptin’s peripheral effect within the body. For example,
Roseweir et al. (2009) found that the central administration
of the kisspeptin antagonist inhibited the firing rate of
GnRH neurons in mouse brain slices, reduced pulsatile
GnRH secretion in female pubertal monkeys, and inhibited
kisspeptin-induced release of LH in rats and mice; they also
found that P234 administration blocked castration-induced
rises of LH levels in sheep, rats, and mice. Furthermore, the
central infusion of P234 has been found to inhibit the onset of
puberty and to block the preovulatory surge of LH in female
rats (Pineda et al., 2010).
Only a few studies have used the peripheral administration
of kisspeptin antagonists (P234, P271). These include the
peripheral administration (intraperitoneal) of P234 and P271
(P234 conjugated to penetratin to enhance transport across
the blood–brain barrier) in rats, with the finding that the
P271 blocked kisspeptin-dependent LH release (Pineda et al.,
2010). Other studies that have used similar administration of
P271 to investigate kisspeptin-GnRH signaling have found
that P271 blunted gonadotropin response to kisspeptin-10
in rats (Pineda et al., 2010) and suppressed GnRH release
in prepubertal female monkeys (Guerriero et al., 2012).
Furthermore, none of these studies examined testosterone
release in response to the peripheral action of kisspeptin.
The present study was specifically designed to investigate
the physiological role of endogenous kisspeptin in the
regulation of testosterone secretion in the adult male rhesus
monkey using the intravenous injection of P234.
2. Materials and methods
2.1. Animals
Five intact adult male rhesus monkeys (Macaca mulatta),
6–8 years old and weighing 8.5–15.5 kg, were used for the

current study. These animals were housed in individual
cages under standard colony conditions in the primate
facility of the Department of Animal Sciences, Quaid-iAzam University. The animals were fed daily with fresh
fruits (0900–0930 hours), hardboiled eggs (1100 hours),
and bread (1300–1330 hours). Water was available ad
libitum. Appetite was monitored for 1 month prior to
the beginning of the experiments. In order to reduce
the effects of stress on the blood sampling, the animals
were habituated to the chair restraint 2 months prior to
commencing the experiments. The duration of restraint
was gradually increased until a daily period of 3 h was
attained. The animals were sedated with ketamine
hydrochloride (Ketler, Astarapin, Germany; 5 mg/kg
BW, intramuscularly) for placement in and removal from
the restraining chair. All experimental protocols of the
present study were approved by the Department of Animal
Science Committee for Care and Use of Laboratory
Animals, Quaid-i-Azam University. Furthermore, all the
animals were kept according to the ethical standards for
the treatment of animals within the guidelines laid down
by the Primate Society of Japan, the National Institutes
of Health (USA), the EC Guide for Animal Experiments,
and the guidelines of the Wild Life Department and other
specific national laws.
2.2. Venous catheterization
To permit sequential withdrawal of blood samples and
intravenous administration of kisspeptin-10 and the
kisspeptin antagonist, the animals were anesthetized
with ketamine (10 mg/kg BW, intramuscularly) and a
Teflon cannula (Vasocan Branule, 0.8 mm/22 G, B. Braun
Melsungen, Germany) was inserted into the saphenous
vein. The distal end of the cannula was attached to a syringe
via a butterfly tube (length 300 mm, volume 0.29 mL, 20
GX3, JMS, Singapore). Experiments were not initiated
until the animals had fully recovered from sedation.
2.3. Pharmacological agents
Ketamine and heparin (Rotex Medica, Germany) were
purchased from local distributors. Human kisspeptin-10
(112-121; KP-10) was purchased from Calbiochem (USA).
The kisspeptin antagonist, P234, was purchased from
Sigma-Aldrich (USA). Working solutions of KP-10 and
P234 were made in normal saline (0.9% NaCl).
2.4. Experimental design
The first experiment was designed to measure the effect of a
kisspeptin receptor blockade on basal plasma testosterone
levels in adult male rhesus monkeys. The animals (n = 5)
were blood-sampled at 15-min intervals for a total period
of 420 min. The animals were injected with saline (0.9
% NaCl) as a vehicle after getting the sample at 60 min.
One week later, the same animals were injected with P234
(using a similar protocol and sampled as described above)
as a single bolus intravenous injection (38.8 µg/kg body
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weight) after 60 min. The dose of P234 was calculated
based on a previously administered dose of P234 applied
centrally in female monkeys (Roseweir et al., 2009). The
peripheral dose used here was 10-fold higher than the
previous dose administered centrally. On a separate
occasion, a 60-min infusion of P234, 60 mL (38.8 µg/kg
body weight) at the rate of 1 mL/min, was infused in the
saphenous vein for testing in 1 animal.
In a second experiment, the effect of the kisspeptin
antagonist on testosterone response to KP-10 was evaluated
in adult male rhesus monkeys (n = 3) by systemically
delivering the antagonist prior to KP-10 stimulation.
Each animal was given a bolus intravenous injection of
P234 (38.8 µg/kg BW) followed by an intravenous KP10 injection (50 µg) 30 min later. For control sampling, 1
week earlier than the treatment, the same animals received
the vehicle followed by a KP-10 injection. Blood samples
were collected at 15-min intervals for 60 min before P234/
vehicle administration and until 210 min after the KP-10
administration. As mentioned above, the doses of P234
and KP-10 were calculated based on previous work in
adult female (Roseweir et al., 2009) and adult male (Wahab
et al., 2010) rhesus monkeys, respectively.
2.5. Blood sampling
Sequential blood samples (2 mL) were obtained in
heparinized syringes. Following withdrawal of each
sample, an equal amount of heparinized (5 IU/mL)
normal saline was administered to avoid blood loss and to
keep the cannula patent. Blood sampling was conducted
between 1000 and 1800 hours. Blood sampling for the first
experiment was done on 19 and 27 October 2010, while
blood sampling for the second experiment was done on 3
and 10 November 2010. Blood samples were centrifuged
at 3000 rpm for 15 min at 4 °C, and plasma was separated
and stored at –20 °C until hormonal analysis.
2.6. Hormone assays
Plasma testosterone (T) levels were measured using a
commercial testosterone ELISA kit (BioCheck, Inc., USA).
The sensitivity of the assay was 0.025 ng/mL. Intra- and
interassay coefficients of variation for the testosterone
assay were 4.4% and 10%, respectively. Plasma adiponectin
levels were measured using the AssayMax human
adiponectin ELISA kit (Assaypro, USA). The sensitivity of
the assay was 0.5 ng/mL. Intra- and interassay coefficients
of variation for the adiponectin assay were 4.1% and 7.2%,
respectively. The assays were performed following the
manufacturer’s instructions.
2.7. Statistical analysis
Statistical comparisons for the mean plasma levels of
T and adiponectin during pre- and post-P234 periods
were made by paired Student’s t-tests. Changes in T
concentrations observed after administering P234 were
assessed by repeated-measures ANOVA followed by
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Dunnett’s multiple comparison test. All data are presented
as mean ± SEM. Differences were considered statistically
significant at P < 0.05.
3. Results
3.1. Effect of peripheral administration of P234 on
plasma testosterone levels
Changes in plasma T levels in pre- and post-P234 injection
periods are shown in Figure 1a. Repeated-measure
ANOVA showed no effect of vehicle or P234 on mean T
levels. Mean plasma T levels observed before and after
intravenous injection of p234 were comparable as there
was no significant difference (Figure 1b). Similarly, a 60min infusion of P234 in 1 animal was not observed to
affect plasma T levels (data not shown).
3.2. Effect of peripheral administration of p234 on KP10–induced testosterone release
Temporal changes in plasma T concentrations after the
KP-10 administration in monkeys pretreated with P234
or vehicle are shown in Figure 2a. Mean plasma T levels
were significantly increased (P < 0.001) in the vehicletreated animals at 105, 120, 135, 150, 180, 195, and 210
min following KP-10 administration, whereas the plasma
T levels were found to be significantly increased (P <
0.001) in the P234-treated group at 90 and 105 min only.
Comparison of mean pre- and post-KP-10 T levels by
t-test revealed that the KP-10 injection significantly (P <
0.05) increased the mean plasma T levels in the vehicletreated animals, but no significant (P > 0.05) changes were
found in the mean plasma T levels after a KP-10 injection
in P234-treated animals (Figure 2b).
3.3. Effect of peripheral administration of peptide 234 on
plasma adiponectin level
The effect of the kisspeptin receptor blockade on plasma
adiponectin levels was used as a positive control for
the peripheral effects of kisspeptin, as kisspeptin had
been found previously to act peripherally to increase
adiponectin secretion (Wahab et al., 2010).
Mean basal plasma adiponectin levels obtained between
–30 and 150 min were found to be significantly decreased
in the P234-treated animals, while no significant decrease
in plasma adiponectin levels was observed in vehicletreated animals (Figure 3a). Adiponectin concentrations
in blood found after kisspeptin stimulation were
significantly reduced following P234 antagonist treatment
in comparison to vehicle pretreatment (P < 0.0034; Figure
3b).
4. Discussion
This study assessed, for the first time, the effect of the
peripheral administration of P234, a GPR54 antagonist,
in adult male rhesus monkeys on plasma levels of
testosterone, the terminal endocrine signal of the HPG
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Figure 1. a) Time course of plasma testosterone levels (mean ± SEM) before
and after vehicle or P234 intravenous bolus injection (38.8 µg/kg BW; arrow)
in adult male rhesus monkeys (n = 5). Repeated-measure ANOVA showed no
effect of the vehicle or antagonist on mean T levels. b) Comparison of mean
± SEM T levels prior to (–60 to 0 min) and after (15–360 min) injection of
p234 or vehicle. Mean T levels remained comparable after vehicle and P234
administration.

axis. The experimental results demonstrated that the bolus
peripheral administration of P234 did not affect basal
testosterone release in the monkeys. These results are
in line with previous data demonstrating that basal LH
levels in adult male rats and basal GnRH levels in adult
female rhesus monkey were not affected by the central
administration of the P234 (Roseweir et al., 2009).
The results presented here also indicated that the
systemic delivery of P234 abated the testosterone
response to kisspeptin, although P234 did not fully
abolish kisspeptin-dependent testosterone release. This
demonstrates that P234 was indeed antagonizing the
GPR54 in this study; an acute central bolus dose of P234 has
been shown to similarly inhibit the kisspeptin-dependent
LH release in intact male rats and mice (Roseweir et al.,
2009). LH is subsequently responsible for the testosterone
release from the Leydig cells of the testis (Saez, 1994). In

castrated male rats and mice, P234 was found to inhibit
the postcastration LH increase, which showed that
P234 blocked GPR54 receptors centrally. Additionally,
penetratin-mixed P234 (P271) administered peripherally
abolished the kisspeptin-dependent LH release in adult
male rats (Pineda et al., 2010), which suggested that
peripheral administration of P234 could cross the blood–
brain barrier (BBB) in the presence of penetratin, an agent
that helps transport macromolecules across the BBB. In
this study, kisspeptin-induced testosterone secretion was
also found to be considerably reduced by the peripheral
administration of P234 without penetratin. However, this
reduction was not a complete inhibition of testosterone
release, which suggested that the P234 did not have a robust
effect. Although there have been preliminary reports of the
presence of GPR54 in the monkey testis (Irfan et al., 2008;
Tariq et al., 2010), initial findings from our laboratory have
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Figure 2. a) KP-10 (50 µg) intravenous bolus injection significantly increased the basal
levels of plasma T (mean ± SEM) in the vehicle-treated adult male rhesus monkeys
(n = 3). Conversely, only a slight and short, albeit significant, elevation change was
observed in the plasma T levels in P234 (38.8 µg/kg BW)-treated animals (n = 3).
b) Comparison of mean ± SEM plasma T before (checkered bars) and after (black
bars) KP-10 (50 µg, intravenous) in vehicle- or P234-treated adult monkeys (n = 3)
revealed that the stimulatory effect of KP-10 on plasma T was no longer significant
following P234 pretreatment.

indicated that kisspeptin does not stimulate testosterone
release from monkey testicular tissue fragments in vitro
(Tariq and Shahab, unpublished data). This indicated
that kisspeptin may not directly interact with testicular
tissue and that the regulation of testosterone release was
independent of any peripheral action by kisspeptin.
Therefore, the moderate inhibitory effect of P234 on
kisspeptin-dependent testosterone release observed in
the present study was likely due to a central perturbation,
despite it not being certain to what extent the P234 peptide
crossed the BBB. Kisspeptin receptors have been shown to
be located on the GnRH fibers in the median eminence
(ME) region outside the BBB (Inoue et al., 2008). Similarly,
GnRH fibers originating in the monkey hypothalamus
that project outside the BBB to the ME have been shown to
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be contacted by kisspeptin fibers in the ME (Ramaswamy
et al., 2008). Therefore, it is possible that the P234 could
access kisspeptin receptors in the ME without passing the
BBB in this study. The finding that a partial inhibition of
testosterone release was found in P234-treated monkeys
suggests that some of the P234 acted on the ME and
blocked GPR54 stimulation, which was potentially
responsible for the impaired testosterone release. It is
likely that the peripherally administered P234 might not
have crossed the BBB and could not block GPR54 at sites
afferent to GnRH neurons; hence, P234 had no effect on
basal testosterone secretion in the present study and/or
on basal LH secretion in other studies (Roseweir et al.,
2009). On the other hand, the peripherally administered
P234 may have blocked GPR54 on GnRH fibers in the
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Figure 3. a) Mean ± SEM plasma adiponectin concentration
observed in the male rhesus monkeys before (hashed bars) and
after (black bars) vehicle or P234 (38.8 µg/kg BW) intravenous
administration (n = 3). A significant reduction of plasma
adiponectin level was evident after P234 injection. b) Mean ±
SEM plasma adiponectin concentration observed in the male
rhesus monkeys treated with vehicle or P234 followed by KP-10
stimulation (n = 3) (P < 0.0034).

ME, which may have provided enough of an effect to
significantly reduce kisspeptin-induced testosterone
release, but not strong enough to completely abolish the
stimulated testosterone release.
Our previous study indicated that the kisspeptin
significantly increased plasma adiponectin levels in

the adult male rhesus monkey (Wahab et al., 2010).
This was a novel finding and suggested that kisspeptin
acted peripherally on adipose tissues and stimulated
adiponectin release. In this study, consistent with our
earlier findings, it was observed that basal and kisspeptinstimulated adiponectin levels were decreased following a
peripheral administration of P234. These findings suggest
that peripheral P234 could access adipocyte GPR54 and
was able to reduce adiponectin release accordingly. The
potential for the P234 bolus injection to cause a reduction
in plasma adiponectin levels and to impair the kisspeptindependent adiponectin release in the current study is
indicative that P234 did not need to cross the BBB in
order to produce antagonistic effects on the kisspeptin–
adiponectin system.
Overall, this study described the effect of peripheral
administration of P234 on plasma testosterone and
adiponectin levels in adult male rhesus monkeys. The results
indicated that P234 moderately reduced the testosterone
response to kisspeptin but did not affect basal testosterone
levels. These findings suggest that P234 administration
modulated the ME kisspeptin-GPR54 signaling involved
in kisspeptin-stimulated testosterone release and may have
not crossed the BBB. In addition, peripheral kisspeptin
signaling could be modulated by P234 and was found
important for adiponectin secretary function in adult
male monkeys as the P234 administration was also found
to decrease adiponectin levels and kisspeptin-dependent
adiponectin response. In summary, the current results
suggest that kisspeptin signaling provides regulation of
testosterone-dependent reproductive function in male
primates in a manner that is regulated predominately
through the central neuroendocrine system. It is also
suggested that peripheral kisspeptin signaling plays an
important role in the regulation of adipokine secretion in
higher primates.
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